Jeffery Michael Watts - 08 Aug 2025 Form 4 Insider Report for FASTENAL CO (FAST)

Role
President and Chief Sales Off.
Signature
/s/ John J. Milek, Attorney-in-Fact
Issuer symbol
FAST
Transactions as of
08 Aug 2025
Net transactions value
-$1,683,247
Form type
4
Filing time
12 Aug 2025, 11:29:20 UTC
Previous filing
06 Jan 2025
Next filing
06 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Watts Jeffery Michael President and Chief Sales Off. 48 LAUREL CR., INGERSOLL, ONTARIO, CANADA /s/ John J. Milek, Attorney-in-Fact 12 Aug 2025 0001691805

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FAST Common Stock Options Exercise $449,955 +32,724 +275% $13.75 44,604 08 Aug 2025 Direct F1
transaction FAST Common Stock Sale $1,572,411 -32,724 -73% $48.05 11,880 08 Aug 2025 Direct
transaction FAST Common Stock Options Exercise $208,000 +16,000 +135% $13.00 27,880 08 Aug 2025 Direct F1
transaction FAST Common Stock Sale $768,790 -16,000 -57% $48.05 11,880 08 Aug 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FAST Employee Stock Option (Right to Buy) Options Exercise $0 -32,724 -100% $0.000000 0 08 Aug 2025 Common Stock 32,724 $13.75 Direct F1, F2
transaction FAST Employee Stock Option (Right to Buy) Options Exercise $0 -16,000 -46% $0.000000 18,612 08 Aug 2025 Common Stock 16,000 $13.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 22, 2019 and May 21, 2024, the Common Stock of Fastenal Company spilt 2-for-1 and the amounts reported have been adjusted to reflect these two stock splits.
F2 The option will fully vest and become exercisable over a period of five years, with 40% vesting and becoming exercisable two years following the date of grant, and the remainder vesting and becoming exercisable proportionately (20%) each year thereafter.